Skip to main content
← Companies
DNA

Ginkgo Bioworks Holdings, Inc.

Data as of Sep 17, 2026
DNA
DNABW
CIK 1830214Biological Products, (No Diagnostic Substances)

Lobbying

$590,000 in reported federal lobbying spend across 15 quarterly filings, most recently Jul 18, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Budget/Appropriations +2$430K7 filings
  • Medical/Disease Research/Clinical Labs$150K4 filings
  • Agriculture$10K3 filings

Latest filings, Jan 2026 onward

FiledRegistrant and subjectAmount
Jul 18, 2026
CROSSROADS STRATEGIES, LLC for GINKGO BIOWORKS INC.
Medical/Disease Research/Clinical Labs Education and outreach on automated lab technology; FY2027 National Defense Authorization Act (H.R.8800/S.4784).
$60,000
Jul 10, 2026
CORNERSTONE GOVERNMENT AFFAIRS, INC. for GINKGO BIOWORKS INC.
Budget/Appropriations · Defense · Medical/Disease Research/Clinical Labs Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education.
$60,000
Apr 20, 2026
CROSSROADS STRATEGIES, LLC for GINKGO BIOWORKS INC.
Medical/Disease Research/Clinical Labs Education and outreach on automated lab technology; FY2027 National Defense Authorization Act.
$60,000
Apr 15, 2026
CORNERSTONE GOVERNMENT AFFAIRS, INC. for GINKGO BIOWORKS INC.
Budget/Appropriations · Defense · Medical/Disease Research/Clinical Labs Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education.
$60,000
Jan 20, 2026
CROSSROADS STRATEGIES, LLC for GINKGO BIOWORKS INC.
Medical/Disease Research/Clinical Labs Education and outreach on automated lab technology.
$30,000
Jan 16, 2026
CORNERSTONE GOVERNMENT AFFAIRS, INC. for GINKGO BIOWORKS INC.
Budget/Appropriations · Defense · Medical/Disease Research/Clinical Labs Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education.
$60,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Ginkgo Bioworks Holdings, Inc. through its SEC registration (CIK 1830214) and tickers DNA, DNABW.

As of: lobbying filings through Jul 18, 2026; contract actions through May 19, 2026. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.